implement process innovation and drive your product from manufacture to market. That’s why the 2019 Cell and Gene Therapy Manufacturing Forum is our biggest yet. With content from over 18 ...
Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments. The ...
Cell therapy and gene therapy represent groundbreaking approaches to treating, preventing, and potentially curing diseases by addressing their underlying causes. These innovative therapeutic ...
Genenta Science has enhanced its collaboration with AGC Biologics by amending their Development and Master Services Agreement to include an exclusive GMP suite in Milan for manufacturing its cell ...
Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system.
10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse ... Improved Prime Editing System Makes Gene-Sized Edits in Human Cells at Therapeutic Levels June 10, 2024 ...
This amendment introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product, ensuring compliance ...
Automated cell ... therapy program for Parkinson’s disease. Under the terms of the agreement, Aspen will integrate Mytos’ iDEM automated cell technology into its 22,000-square-foot ...